News & Updates

COVID-19 appears to alter the menstrual cycle and impair mental health in women hospitalized for the disease, a recent study has found.

An investigational digital intervention delivered through a video game–based interface, called AKL-T03, significantly improves attention span and cognitive functioning among patients with major depression when compared to a control condition, a study has shown. In addition, it is well tolerated and has minimal adverse events.

For patients with depression who struggle to fall asleep, electroacupuncture can help with getting a better night’s sleep, with sustained effects, as shown in a study.

Selective serotonin reuptake inhibitors (SSRIs) can prevent and treat depression following stroke, in addition to improving anxiety, dependence, motor function, and cognitive function—benefits that are only reproducible with citalopram but not fluoxetine, according to a meta-analysis said to be the most up to date.

Treatment with dextromethorphan-bupropion (AXS-05) significantly improves depressive symptoms relative to bupropion alone and is well tolerated in patients with major depression, results of a phase II trial have shown.

The connectivity strength of the ventral striatum (VS) within the reward network demonstrates links to depressive disorders and anhedonia from mid to late adolescence, which indicates the role played by this circuitry in depression changes with age, reveals a study.

Children with autism spectrum disorders (ASD) are highly likely to suffer from clinical-level anxiety, a recent study has found. ASD severity and sensory processing difficulties appear to aggravate anxiety in this population.

While treatment with isotretinoin for acne is said to have a negative impact on mental health, its use appears to instead mitigate the excess psychiatric risk associated with treatment-resistant moderate-to-severe acne, as reported in a large study.